Citation Impact

Citing Papers

Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
2018
Chronic Kidney Disease and Albuminuria in Children with Sickle Cell Disease
2011
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol
2011 Standout
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Sequence and exon-intron organization of the DNA encoding the alpha I domain of human spectrin. Application to the study of mutations causing hereditary elliptocytosis.
1989 StandoutNobel
Mechanisms of Thrombus Formation
2008 Standout
Eicosanoids in sickle cell disease: Potential relevance of neutrophil leukotriene B4 to disease pathophysiology
2002
Haemoglobinopathies and the rheumatologist
2016
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Pathogenesis and Treatment of Sickle Cell Disease
1997
Prevalence and reversibility of lower airway obstruction in children with sickle cell disease
2001
Acute chest syndrome of sickle cell disease: new light on an old problem
2001
CASK and Protein 4.1 Support F-actin Nucleation on Neurexins
2001 StandoutNobel
Macromolecular crowding: obvious but underappreciated
2001 Standout
The Influence of Macromolecular Crowding and Macromolecular Confinement on Biochemical Reactions in Physiological Media
2001 Standout
Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. I. Biochemical identification of rearrangements in the spectrin/actin binding domain and functional characterizations.
1990 StandoutNobel
Genetic Analysis of Innate Immunity
2006 StandoutNobel
New therapies in sickle cell disease
2002
Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience
2004
Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
2012 Standout
Infection in sickle cell disease: A review
2009
Clinical classification of pulmonary hypertension
2004 Standout
Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. II. Determination of molecular genetic origins of rearrangements.
1990 StandoutNobel
Membrane Mechanisms and Intracellular Signalling in Cell Volume Regulation
1995
Membrane Dynamics of the Water Transport Protein Aquaporin-1 in Intact Human Red Cells
1999 StandoutNobel
Airway hyperreactivity detected by methacholine challenge in children with sickle cell disease
2007
Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
2006
Clinical management of adult sickle-cell disease
2012
Physical Therapy Alone Compared with Core Decompression and Physical Therapy for Femoral Head Osteonecrosis in Sickle Cell Disease
2006
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Sickle cell disease: renal manifestations and mechanisms
2015
Identification of the protein 4.1 binding site to phosphatidylserine vesicles
1988
Differential control of band 3 lateral and rotational mobility in intact red cells.
1994 StandoutNobel
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
2000
Investigational drugs in sickle cell anemia
2009
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
1990 Nature
Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography
1998 Standout
Sickle-cell disease
2010 Standout
Identification of the haemoglobin scavenger receptor
2001 StandoutNature
Airway hyperresponsiveness and acute chest syndrome in children with sickle cell anemia
2007
Monocytes and macrophages in malaria: protection or pathology?
2012
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
2006
Painful Episodes in Children With Sickle Cell Disease and Asthma are Temporally Associated With Respiratory Symptoms
2006
Sickle red cell dehydration: mechanisms and interventions
2002
Identification of the Membrane Attachment Sites for Protein 4.1 in the Human Erythrocyte
1995
Homology requirements for unequal crossing over in humans.
1991 StandoutNobel
Antithrombotic Therapy in Neonates and Children
2008
Expression of aquaporin isoforms during human and mouse tooth development
2003 StandoutNobel
Therapeutic Strategies for Prevention of Sickle Cell Dehydration
2001
Long-term hydroxyurea treatment in young sickle cell patients
1999
The paradox of hemoglobin SC disease
2003
A Putative Src Homology 3 Domain Binding Motif but Not the C-terminal Dystrophin WW Domain Binding Motif Is Required for Dystroglycan Function in Cellular Polarity in Drosophila
2007 StandoutNobel
Red cell indices in classification and treatment of anemias
2013
Pharmacologic Modulation of Fetal Hemoglobin
2001
Proteolipidic Composition of Exosomes Changes during Reticulocyte Maturation
2011
Lung Function and Airway Hyperresponsiveness in Adult Patients with Sickle Cell Disease
2006
Ion-transporting activity in the murine colonic epithelium of normal animals and animals with cystic fibrosis
1994 StandoutNobel
The spectrin-actin junction of erythrocyte membrane skeletons
1989
Pulmonary Complications of Sickle Cell Anemia
2001
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C
1993
Extracellular DNA traps promote thrombosis
2010 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action:  Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Identification, purification, and partial characterization of a novel Mr 28,000 integral membrane protein from erythrocytes and renal tubules.
1988 StandoutNobel
Percutaneous Implantation of Autologous Bone Marrow Osteoprogenitor Cells as Treatment of Bone Avascular Necrosis Related to Sickle Cell Disease
2008
Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease
2000
Hereditary elliptocytosis, spherocytosis and related disorders: Consequences of a deficiency or a mutation of membrane skeletal proteins
1987
Hemostatic Alterations in Sickle Cell Disease: Relationships to Disease Pathophysiology
2001
Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice
2012
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery
2019
Hydroxyurea for Sickle Cell Disease: A Systematic Review for Efficacy and Toxicity in Children
2008
Mouse K-Cl cotransporter KCC1: cloning, mapping, pathological expression, and functional regulation
1999
Hereditary Elliptocytosis and Related Disorders
1985
Alteration of the erythrocyte membrane skeletal ultrastructure in hereditary spherocytosis, hereditary elliptocytosis, and pyropoikilocytosis
1990 StandoutNobel
The characterization of protein 4.1 Presles, a shortened variant of RBC membrane protein 4.1
1985
Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family.
1991 StandoutNobel
Cloning, characterization, and gene organization of K-Cl cotransporter from pig and human kidney andC. elegans
1998
Customer Engagement
2011 Standout
Phospholipase A2 levels in acute chest syndrome of sickle cell disease
1996
Guidelines for the Primary Prevention of Stroke
2014 Standout
The distribution of erythrocyte phospholipids in hereditary spherocytosis demonstrates a minimal role for erythrocyte spectrin on phospholipid diffusion and asymmetry
1993 StandoutNobel
Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
2009 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Double inheritance of an alpha I/65 spectrin variant in a child with homozygous elliptocytosis
1986
A molecular study of heterozygous protein 4.1 deficiency in hereditary elliptocytosis
1988
Erythrocyte K-Cl cotransport: properties and regulation
1992
Delayed hemolytic transfusion reaction in children with sickle cell disease
2011
Dehydration of transferrin receptor-positive sickle reticulocytes during continuous or cyclic deoxygenation: role of KCl cotransport and extracellular calcium
1996
New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36
2002
The ethics of a proposed study of hematopoietic stem cell transplant for children with “less severe” sickle cell disease
2014
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
?-Thalassemia haplotypes in the Algerian population
1987
Updates in Hemoglobinopathies
2013
Membrane Transport in Sickle Cell Disease
2002
Localization of the protein 4.1-binding site on human erythrocyte glycophorins C and D
1994
Iron-Deficiency Anemia
2015 Standout
Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia
2006
Distinct variants of erythrocyte protein 4.1 inherited in linkage with elliptocytosis and Rh type in three white families
1988 StandoutNobel
How I manage cerebral vasculopathy in children with sickle cell disease
2015
A review on the adsorption of heavy metals by clay minerals, with special focus on the past decade
2016 Standout
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management
2012
Erythrocyte Mr 28,000 transmembrane protein exists as a multisubunit oligomer similar to channel proteins.
1991 StandoutNobel
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Urea alters set point volume for K-Cl cotransport, Na-H exchange, and Ca-Na exchange in dog red blood cells
1993
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease
2008
Oral magnesium pidolate: effects of long‐term administration in patients with sickle cell disease
2000
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Spα1/65 hereditary elliptocytosis in North Africa
1986
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Swelling activation of K-Cl cotransport in LK sheep erythrocytes: a three-state process.
1993
Sodium-Potassium-Chloride Cotransport
2000 Standout
Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes.
2006

Works of D. Bachir being referenced

The Natural History of Asymptomatic Osteonecrosis of the Femoral Head in Adults with Sickle Cell Disease
2006
Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males
2008
Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.
1997
CD36 deficiency is frequent and can cause platelet immunization in Africans
1999
Severe Pneumococcal Sepsis and Meningitis in Human Immunodeficiency Virus-Infected Adults with Sickle Cell Disease
1992
Estimation of the difference in HbF expression due to loss of the 5'  -globin BCL11A binding region
2012
The involvement of the Ca-dependent K channel and of the KCl co-transport in sickle cell dehydration during cyclic deoxygenation
1994
Aggregation of mononuclear and red blood cells through an  4 1-Lu/basal cell adhesion molecule interaction in sickle cell disease
2010
Transfusion et alloimmunisation chez les patients drépanocytaires
1994
THE NATURAL HISTORY OF SYMPTOMATIC OSTEONECROSIS IN ADULTS WITH SICKLE-CELL DISEASE
2003
Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence
1993
Preliminary report of a toxicity study of hydroxyurea in sickle cell disease
1999
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease
2007
Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism.
1996
Pulmonary function in sickle cell disease with or without acute chest syndrome
1998
Red cell membrane sialoglycoptein β in homozygous and heterozygous 4.1(−) hereditary elliptocytosis
1985
Hemoglobin Bart’s in Northern Algeria
1981
Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients.
1991
Characteristics and Outcome of Connective Tissue Diseases in Patients with Sickle-Cell Disease: Report of 30 Cases
2008
Early glomerular dysfunction in patients with sickle cell anemia
1998
Hemoglobin variants and activity of the (K+Cl-) cotransport system in human erythrocytes
1992
Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619.
1993
The heterozygous form of 4.1(-) hereditary elliptocytosis [the 4.1(-) trait]
1985
Rankless by CCL
2026